- Home
- Unlocking the immune system
Unlocking the immune system
The immune system is meant to defend the body against diseases—but for millions of people around the world, that’s not always the case. That’s why we are committed to advancing scientific and technological solutions that not only provide treatment against diseases but offer the possibility to recalibrate the body’s ability to fend for itself. At Johnson & Johnson, we are unlocking the immune system to reimagine living and restore living to life.
Innovating in Health&Care
Why is targeting IL-23 potentially important for treating psoriasis and other diseases?
This pro-inflammatory protein is the target of Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
The future of immunology
Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world
Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer.
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
Juvenile myasthenia gravis: Inside one adolescent’s journey
The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
“Patients are the center of everything": Meet the scientist leader dedicated to developing effective IBD treatments
Her natural curiosity, determination and fascination with science inspired Esi Lamousé, M.D., Ph.D., to pursue a career that’s helped bring innovative therapies for inflammatory bowel disease to patients in need around the world.
5 things we now know about eczema (a.k.a., atopic dermatitis)
The most common inflammatory skin disease causes scaly patches, blisters and severe itching, but it’s far more than just a cosmetic concern. Learn why Johnson & Johnson is focused on helping the millions living with this painful condition.
Is chronic inflammation treatable? Learn more about this serious condition
Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.
What is warm autoimmune hemolytic anemia?
Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.
Quiz: How much do you know about psoriasis?
The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. Take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common immune-mediated disease.
More from Johnson & Johnson
Shockwave: Inside the development of a cutting-edge system to treat coronary artery disease
Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.
What is asthma?
This chronic inflammatory disease causes flareups that make it difficult to breathe. Learn about the two types of asthma, common triggers and how Johnson & Johnson is developing approaches that may lead to better treatments.
Johnson & Johnson named a 2026 Fortune World’s Most Admired Company
The company made the prestigious list for the 24th consecutive year, thanks to its dedication to innovation and social responsibility, among other criteria.